González-Martín, A., Pothuri, B., Vergote, I., Christensen, R., Graybill, W., Mirza, M., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., Baumann, K., Jardon, K., Redondo, A., Moore, R., Vulsteke, C., O'Cearbhaill, R., Lund, B., Backes, F., Barretina-Ginesta, P., Haggerty, A., Rubio-Pérez, M., Shahin, M., Mangili, G., Bradley, W., Bruchim, I., Sun, K., Malinowska, I., Li, Y., Gupta, D., & Monk, B. (n.d.). niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study. International journal of gynecological cancer, 29, A9–A10. http://access.bl.uk/ark:/81055/vdc_100144712046.0x000014